浙江洁美电子科技股份有限公司投资者关系活动记录表 编号：20260116 | | | ☑特定对象调研 □媒体采访 | | | | | | □分析师会议 □业绩说明会 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 投资者关系 | | | | | | | | | | | | | □新闻发布会 | | | | | | □路演活动 | | | 活动类别 | | □现场参观 | | | | | | | | | | | ☑其他（电话会议） | | | | | | | | | 参与单位名称 | | 山西证券 | | | | | | | | | 时 | 间 | 2026 年 至 17:20 | 1 | 月 | 16 | 日下午 | 16:20 | | | | 地 | 点 | 浙江省杭州市拱墅区大关路 100 | | | | | | 号绿地中央广场 | 10 幢 24 层会议室 | | 上市公司接待 | | 董事、副总经理、董事会秘书：张君刚 | | | | | | | | | 人员姓名 | | 投资者关系助理：李彦霖 | | | | | ...

|  投资者关系 | 特定对象调研 □分析师会议 □媒体采访 | | --- | --- | | 活动类别 | □业绩说明会 □新闻发布会 □路演活动 | | | □现场参观 □其他 （请文字说明其他活动内容） | | | Ai-Squared Management Limited Channing Li，Aspex Management | | | (HK) Limited Lewis Yang，Aspoon Capital Limited Tony Wang， | | | Broad Peak Investment Advisers PTE Ltd Amy Xiong，CPPIB Vennie | | | Kang，DE Shaw & Co LP Yongyan Zhu，Everflow Investment Management | | | Limited Richard Lu，ForwardEdge Investment Limited Patrick Huo， | | | HSBC Global Asset Management (HongKong) Limited Caroline | | 参与 ...

Group 1: Product Development and Strategy - Both "Whiteout Survival" and "Endless Winter" are performing steadily, with "Kingshot" in a rapid growth phase. The company has sufficient resources, ensuring no single product faces resource allocation issues [1] - The company employs a "horse racing" mechanism for new product incubation, enhancing recovery efficiency and success rates [1] - The company has accumulated substantial R&D and user acquisition experience in the casual gaming and SLG sectors, with successful integration of SLG+X products reinforcing its competitive edge [1] Group 2: Financial Management and Personnel Expansion - The company has expanded its personnel in response to rapid business growth, maintaining a balance between cautious expansion and efficiency [2] - Financial expenses are expected to improve as the company continues to optimize its financial structure and manage past debts effectively [2] Group 3: Market Insights and Competitive Landscape - There is little difference in overseas user acquisition channels for casual and SLG games, although content and frequency may vary based on target demographics. Casual games are projected to have longer lifecycles and more stable customer bases [2] - The impact of product imitation exists, but the company has established significant product barriers and user depth differences, alongside strong user acquisition and operational capabilities [2] - The gaming industry is experiencing multiple favorable factors, including supportive policies, focused industry professionals, and AI enhancements, indicating a supply-driven demand model [2]

江阴海达橡塑股份有限公司投资者关系活动记录表 编号：2026-01 | 投资者关系活动 | ■特定对象调研 □分析师会议 | | --- | --- | | 类别 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他： | | 参与单位名称 | 中信证券 财通基金 | | 时间 | 2026 年 1 月 20 日 | | 地点 | 公司会议室 | | 上市公司接待人 | 钱振宇---董事长、总经理 | | 员姓名 | 胡蕴新---董事、副总经理、董事会秘书 | | | 吴纪高---海达新能源总经理 | | | 1、总体介绍公司业务板块情况。 | | | 2、请问 2025 年经营情况及以后的业务展望： | | | 答：2025年公司生产经营正常，其中 1-9月实现营业收入 26.67 | | | 亿元，较上年同期增长 13.43%，归属于上市公司股东的净利 | | | 润为 1.67 亿元, 较上年同期增长 42.99%。 | | | 未来，公司将立足中高端定位，围绕橡胶制品密封、减振 | | | 两大基本功能，发挥多领域配套战略和技术融合的优势，夯实 ...

证券代码:300818 证券简称:耐普矿机 编号:2026-002 江西耐普矿机股份有限公司 投资者关系活动记录 | | 特定对象调研 | | 分析师会议 | | | --- | --- | --- | --- | --- | | 投资者关系活 | 媒体采访 | | 业绩说明会 | | | 动类别 | 新闻发布会 | 路演活动 | | | | | 现场参观 | | 一对一沟通 | | | | 其他：线上交流 | | | | | | 公司 | 姓名 | 公司 | 姓名 | | | 民生加银基金 | 付裕 | 嘉实基金 | 高群山 | | | | 祝婳婷 | | | | | 国海富兰克林基金 | 覃晶晶 | 兴证全球基金 | 黄煜杰 | | | 中天汇富基金 | 古道和 | 紫金信托 | 魏宁伟 | | | 京管泰富基金 | 郎朗 | 交银施罗德基金 | 庄旨歆 | | | 国寿安保基金 | 初梓健 | 东海证券 | 王敏君 | | | 玄卜投资 | 夏一 | 粤佛私募基金 | 曹志平 | | | 共青城鼎睿资产 | 王可丹 | 瑞民私募基金 | 黄鹏 | | | 华夏久盈资产 | 桑永亮 | ...

证券代码：301045 证券简称：天禄科技 苏州天禄光科技股份有限公司 投资者关系活动记录表 编号：2026-005 投资者关系活 动类别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 ☑ 路演活动 □现场参观 □电话会议 □其他： （请文字说明其他活动内容） 参与单位名称 申万菱信、华宝基金、东方证券资管 时间 2026 年 1 月 20 日 地点 上海 公司接待人员 姓名 投资者关系总监：李艳茹女士 投资者关系活 动主要内容介 绍 投资者提出的问题及公司回复情况 1、TAC膜主要依赖从日本进口，请介绍目前全球主要厂 商。 目前，TFT级偏光片用TAC膜供应商主要有五家：日本的富 士胶片、日本的柯尼卡美能达、韩国的晓星化学、中国台湾的 达辉和日本的瑞翁。其中富士胶片、柯尼卡美能达、瑞翁合计 约占全球市场的 80%，由此可以看出TFT级偏光片用TAC膜是一 款基本由日本厂商垄断的产品。 2、TAC膜的市场空间及竞争格局如何，近期中日关系对项 目推进有何影响？ 根据市场机构数据，TAC膜的需求量 2025 年有望达到 12.29 亿平方米。其下游的面板环节超过 70%产能在中国大陆，偏光 ...

Group 1: Company Overview and Leadership - Shenzhen Longkun Technology Co., Ltd. is represented by Chairman Chen Jianxiang and other key personnel during investor relations activities [1][3] - The company is actively engaging with various financial institutions and analysts to discuss its business strategies and developments [2][3] Group 2: AI Application Center - The AI Smart Application Center was officially established on January 11, 2025, to enhance internal efficiency and management through AI technology [4] - The center focuses on two main areas: internal management and digital applications related to the company's core business in organic waste resource utilization and bioenergy [4] Group 3: Collaboration with Sinopec - Longkun Technology is collaborating with Sinopec to build a full industrial chain for the collection, pre-treatment, and deep processing of waste oil into biodiesel and sustainable aviation fuel (SAF) [4] - The partnership is progressing steadily, with a signing ceremony held on August 15, 2025, although specific details are under confidentiality agreements [4] Group 4: HMO Product Development - The company has completed trial production for its first phase of HMO products, with a capacity of 260 tons, which has passed inspections from multiple downstream clients [5] - HMO products include various types such as 2'-FL, 3-FL, and LNnT, with some already approved by health authorities [6] Group 5: SAF Policy and Market - Thailand has implemented a mandatory blending policy for sustainable aviation fuel, requiring a 1% mix starting January 1, 2026, to support carbon neutrality goals [6] - In China, the target for SAF consumption is set at 20,000 tons for 2025, with a cumulative goal of 50,000 tons during the 14th Five-Year Plan period [6][7] Group 6: Project Progress - The Beijing Tongzhou project is on track for completion and trial operation in the second half of 2026 [7]

证券代码：300953 证券简称：震裕科技 宁波震裕科技股份有限公司 投资者关系活动记录表 编号：2026-001 公司 2025 年前三季度实现营业收入 65.93 亿元，同比增长约 31.47%； 归母净利润 4.12 亿元，同比增长约 138.93%；扣非归母净利润 3.98 亿元， 同比增长约 153.42%。其中锂电池结构件业务前三季度营业收入同比增长 超过 45%，毛利同步回升明显。 公司 2025 年度业绩预告，预计 2025 年实现营业收入为 93 亿元～103 亿元、归母净利润 5 亿元~5.5 亿元、扣非后净利润 4.8 亿元~5.3 亿元。 二、互动环节（部分重复及类似问题已经合并）： Q：公司 2025 年业绩大幅增长的原因？2026 年是否能够延续 2025 年增 长的势头？ A：根据公司 2026 年 1 月 15 日披露的 2025 年度业绩预告，预计 2025 年 实现归母净利润 5 亿元~5.5 亿元，扣非后净利润 4.8 亿元~5.3 亿元。2025 年公司经营计划有序开展，主营业务销售收入持续增长（初步测算 2025 年度营业收入预计为 93 亿元～103 亿元），产能利 ...

Group 1: Company Overview and AI Medical Layout - Guangzhou Wanfu Biological Technology Co., Ltd. has been investing in AI medical since 2018, aiming to become a leading enterprise in the domestic AI medical field through a "merger + hospital end + consumer end" strategy [2][4] - The company’s investment in Saiweisen Medical Technology led to the first domestic Class III medical device registration for cervical cancer cell digital pathology software in February 2025 [2][3] - Wanfu has developed the "Wanfu Smart Inspection" AI platform for hospitals, which has been implemented in various medical scenarios [3][4] Group 2: Investment and Collaboration - The company collaborates with Saiweisen, Shengqiang, and Yizhun Intelligent to enhance diagnostic capabilities through software and hardware integration [4][5] - The partnership aims to leverage each company's strengths in imaging, pathology, and laboratory testing to capture opportunities in AI applications [4][5] Group 3: Product Development and Market Position - Saiweisen has received the first Class III certification for AI-assisted diagnosis in gynecology, with ongoing clinical trials for non-gynecological applications [5][6] - Shengqiang Technology has developed a comprehensive digital pathology solution, covering approximately 2,000 hospitals domestically and 12 overseas regions [7][8] - Yizhun Intelligent holds 15 Class II and 6 Class III certifications, with a focus on ultrasound AI technology, which is more complex than radiology AI [9][10] Group 4: Market Trends and Future Outlook - The introduction of new policies is expected to significantly increase the volume of digital slices in the pathology market, creating substantial market capacity [8][9] - The AI medical sector is projected to grow rapidly, with a focus on enhancing brand influence and operational efficiency through innovative AI applications [10][11] - The company anticipates a recovery in domestic business in 2026, supported by overseas growth driven by various platforms [12][13]

宁波卡倍亿电气技术股份有限公司 投资者关系活动记录表 证券代码： 300863 证券简称：卡倍亿 6.请介绍一下公司与矩阵超智的合作？ 答：投资者您好！公司墨西哥生产基地已进入产能爬坡阶段，目 前正按计划推进生产经营工作，经营状况良好。公司也曾于 2025 年 3 月 28 日发布公告，公司的墨西哥子公司收到了某国际知名 汽车线束公司的采购定点通知。公司的墨西哥子公司作为该客户 的合格供应商，将为该客户的墨西哥工厂提供汽车用线缆产品, 定点项目具体情况:供货产品为汽车用线缆产品，供货周期为 2025 年至 2027 年，合计供货数量约 164 万公里，预计销售总额 折合人民币约 10 亿元。此外，墨西哥子公司也在与安波福、矢 崎等传统大客户洽谈合作，相关业务进展顺利。 答：投资者您好！公司与上海矩阵超智系统集成有限公司（简称 "矩阵超智"）已正式签署战略合作协议，双方将围绕技术创新、 供应链协同与产业共建等方面展开深度合作，共同推进人形机器 人业务的快速发展。根据战略合作协议，双方将建立长期、稳定 的战略合作伙伴关系。卡倍亿的目标是成为矩阵超智在机器人线 | 缆等领域的重要供应商。双方将通过技术协同、联合开发 ...